” Analyst coverage for Trendlines…Six companies announce funding … Medical webinar open for registration …”
The Trendlines Group is pleased to announce investments in Arcuro Medical, FruitSpec, ProArc Medical and Phytolon.
Vessi Medical, a portfolio company of The Trendlines Group announced that it secured $1.7 million in funding for its cryoablation solution for superficial bladder cancer. Participating in the financing were Agriline, The Trendlines Group, the Israel Innovation Authority, and ExitValley investors. Vessi’s first-in-human (FIH) study demonstrating safety and efficacy of the Vessi intravesical cryotherapy device […]
“Trendlines expands in Singapore and Shanghai … New funding for Phytolon and PregnanTech … Hargol FoodTech in international media”
Insectta is making leaps and bounds in food waste recycling work with their army of insects.
From biblical plague to modern day protein, one Israeli firm wants to make locusts a sustainable food choice in the Holy Land and beyond. As for whether or not the insects are kosher, the answer is not so simple.
Trendlines Labs Singapore will invent and develop novel medical technologies, innovating and creating value for Trendlines’ portfolio companies and strategic partners
“Interview with Steve Rhodes… PregnanTech funding on ExitValley… Arcuro Medical and ST Stent launch sales”
Barak Singer, CEO, Trendlines Incubators Israel was interviewed by Chiportal on investment during the COVID-19 crisis.
“1st remote AGM and SGM … 2nd milestone for Arcuro … 3rd investment for Trendlines Agrifood Fund … “